We are live on
!
Find out more
Puma Biotechnology
PBYI
PBYI
119 hedge funds and large institutions have $889M invested in Puma Biotechnology in 2016 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 48 increasing their positions, 33 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
45% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 33
44% more call options, than puts
Call options by funds: $13.8M | Put options by funds: $9.56M
5.65% less ownership
Funds ownership: 99.26% → 93.61% (-5.6%)
11% less funds holding
Funds holding: 133 → 119 (-14)
41% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 32
65% less capital invested
Capital invested by funds: $2.52B → $889M (-$1.63B)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
119
Holders Change
-14
Holders Change %
-10.53%
% of All Funds
3.17%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
19
Increased
48
Reduced
33
Closed
32
Calls
$13.8M
Puts
$9.56M
Net Calls
+$4.2M
Net Calls Change
-$30M
Top Buyers
| 1 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$61.4M |
| 2 |
O
OrbiMed
New York
|
+$23.3M |
| 3 |
State Street
Boston,
Massachusetts
|
+$13.6M |
| 4 |
VAM
Visium Asset Management
New York
|
+$9.76M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$9.59M |
